Parth Kishore Shah | Health | Best Researcher Award Published on 26/09/202526/09/2025 by Civil Engineering Parth Kishore Shah | Health | Best Researcher Award MD | SURGONE PC | United States Parth Kishore Shah is a distinguished surgical oncologist whose research field spans thyroid cancer, parathyroid disorders, gastrointestinal malignancies, melanoma, esophageal cancer, and complex general surgical oncology. His work integrates clinical practice with translational research, emphasizing outcomes-based studies, surgical techniques, and innovations in cancer treatment. Shah has contributed to advancing knowledge in thyroid malignancy predictors, parathyroidectomy strategies, and management of neuroendocrine tumors, while also exploring molecular markers such as CTNNB-1 mutations in adrenocortical carcinoma. His international exposure at institutions like Memorial Sloan-Kettering Cancer Center and Moffitt Cancer Center strengthened his focus on advanced oncologic interventions, including heated intraperitoneal chemotherapy (HIPEC) and multidisciplinary approaches to sarcoma and melanoma. He has been actively involved in large-scale clinical trials such as the MELMART-II trial for melanoma margin assessment, DecisionDx studies for sentinel lymph node biopsy prediction, and Delphi studies addressing rare tumors like dedifferentiated liposarcoma. Shah’s extensive portfolio includes numerous oral presentations, posters, and peer-reviewed publications addressing both surgical outcomes and translational oncology. Beyond clinical research, he has played leadership roles in developing cancer treatment guidelines and initiatives such as Colorado’s Opioid Solution (CO’s CURE), focusing on safe prescribing practices and patient-centered cancer care. His scholarly impact is reflected in publications covering diverse oncologic domains, from parathyroid disease to esophageal and pancreatic cancers, while his contributions to book chapters highlight expertise in gastrointestinal and abdominal surgical oncology. With ongoing involvement in national and international cancer societies, Shah’s research continues to shape oncologic surgery, integrating evidence-based practice with innovation. His contributions extend into community education, multidisciplinary collaboration, and the mentoring of future surgeons. His academic and clinical achievements highlight a career deeply committed to improving cancer outcomes through research, education, and surgical excellence. Parth Kishore Shah’s work has earned recognition across multiple professional societies, and his scholarly influence is evident with 137 Citations, 7 Documents and an h-index of 5. Profile: Scopus Featured Publications: Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: A propensity matched analysis. (2021). Diseases of the Esophagus. Advance online publication.
Parth Kishore Shah | Health | Best Researcher Award MD | SURGONE PC | United States Parth Kishore Shah is a distinguished surgical oncologist whose research field spans thyroid cancer, parathyroid disorders, gastrointestinal malignancies, melanoma, esophageal cancer, and complex general surgical oncology. His work integrates clinical practice with translational research, emphasizing outcomes-based studies, surgical techniques, and innovations in cancer treatment. Shah has contributed to advancing knowledge in thyroid malignancy predictors, parathyroidectomy strategies, and management of neuroendocrine tumors, while also exploring molecular markers such as CTNNB-1 mutations in adrenocortical carcinoma. His international exposure at institutions like Memorial Sloan-Kettering Cancer Center and Moffitt Cancer Center strengthened his focus on advanced oncologic interventions, including heated intraperitoneal chemotherapy (HIPEC) and multidisciplinary approaches to sarcoma and melanoma. He has been actively involved in large-scale clinical trials such as the MELMART-II trial for melanoma margin assessment, DecisionDx studies for sentinel lymph node biopsy prediction, and Delphi studies addressing rare tumors like dedifferentiated liposarcoma. Shah’s extensive portfolio includes numerous oral presentations, posters, and peer-reviewed publications addressing both surgical outcomes and translational oncology. Beyond clinical research, he has played leadership roles in developing cancer treatment guidelines and initiatives such as Colorado’s Opioid Solution (CO’s CURE), focusing on safe prescribing practices and patient-centered cancer care. His scholarly impact is reflected in publications covering diverse oncologic domains, from parathyroid disease to esophageal and pancreatic cancers, while his contributions to book chapters highlight expertise in gastrointestinal and abdominal surgical oncology. With ongoing involvement in national and international cancer societies, Shah’s research continues to shape oncologic surgery, integrating evidence-based practice with innovation. His contributions extend into community education, multidisciplinary collaboration, and the mentoring of future surgeons. His academic and clinical achievements highlight a career deeply committed to improving cancer outcomes through research, education, and surgical excellence. Parth Kishore Shah’s work has earned recognition across multiple professional societies, and his scholarly influence is evident with 137 Citations, 7 Documents and an h-index of 5. Profile: Scopus Featured Publications: Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: A propensity matched analysis. (2021). Diseases of the Esophagus. Advance online publication.